The New Frontier of Medicine: Building Exosome Therapies to Last
The field of cell and gene therapy is witnessing a seismic shift, and exosomes are at the heart of it. These tiny biological messengers hold immense promise for treating everything from autoimmune diseases to tissue repair. But moving from a research concept to a viable medicine is the real challenge. For developers, creating a robust Chemistry, Manufacturing, and Controls (CMC) strategy from the very beginning is no longer optional—it's essential. This early groundwork is what separates a promising discovery from a tangible treatment you might one day search for as ‘ exosome therapy near me ’. We often see brilliant scientific ideas stumble during scale-up. The process that works perfectly in a small lab flask often fails in larger bioreactors. That’s why thinking about manufacturing and quality control early isn't just about checking regulatory boxes. It's about building a solid foundation for your entire program. Start with the End in Mind: Manufacturing and Scalability ...